Potential of Nanomaterials as Movers and Packers for Drug Molecules

[1] B.E. Barry, J. Shatkin, Nanomaterials for drug delivery: Potential benefits and risks. http: /www. ispeboston. org/technical_articles/boston_area_nanomaterials_for_drug_delivery_potential_benefits_and_risks. html. Accesed on 12/8/2014 (2006).

Google Scholar

[2] W.H. De Jong, P.J.A. Borm, Drug delivery and nanoparticles: Applications and hazards, Int. J. Nanomedicine 3 (2008) 133-149.

Google Scholar

[3] W.B. Weber, Physicochemical Process for Wastewater Control, Wiley, New York (1992).

Google Scholar

[4] E.I. Rabea, M.E. Badawy, C.V. Stevens, G. Smagghe, W. Steurbaut, Chitosan as antimicrobial agent: applications and mode of action, Biomacromolecules 4 (2003) 1457-1465.

DOI: 10.1021/bm034130m

Google Scholar

[5] Y.C. Chung, H.L. Wang, Y.M. Chen, S.L. Li, Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens, Bioresour. Technol. 88 (2003) 179-184.

DOI: 10.1016/s0960-8524(03)00002-6

Google Scholar

[6] L. Qi, Z. Xu, X. Jiang, C. Hu, X. Zou, Preparation and antibacterial activity of chitosan nanoparticles, Carbohydr. Res. 339 (2004) 2693-2700.

DOI: 10.1016/j.carres.2004.09.007

Google Scholar

[7] S. Tin, K.R. Sakharkar, C.S. Lim, M.K. Sakharkar, Activity of chitosans in combination with antibiotics in Pseudomonas aeruginosa, Int. J. Biol. Sci. 5 (2009) 153-160.

DOI: 10.7150/ijbs.5.153

Google Scholar

[8] J. Chen, L. Huang, H. Lai, C. Lu, M. Fang, Q. Zhang, X. Luo, Methotrexate-loaded PEGylated chitosan nanoparticles: Synthesis, characterization, and in vitro and in vivo antitumoral activity, Mol. Pharm. 11 (2013) 2213-2223.

DOI: 10.1021/mp400269z

Google Scholar

[9] S.J. Lee, A. Lee, S.R. Hwang, J.S. Park, J. Jang, M.S. Huh, D.G. Jo, S.Y. Yoon, Y. Byun, S.H. Kim, I.C. Kwon, I. Youn, K. Kim, TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis, Mol. Ther. 22(2) (2014).

DOI: 10.1038/mt.2013.245

Google Scholar

[10] P. Mukhopadhyaya, R. Mishrab, D. Ranac, P.P. Kundu, Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review, Prog. Polym. Sci. 37 (2012) 1457-1475.

DOI: 10.1016/j.progpolymsci.2012.04.004

Google Scholar

[11] K. Nagpal, S.K. Singh, D.N. Mishra, Chitosan nanoparticles: A promising system in novel drug delivery, Chem. Pharm. Bull. 58 (2010) 1423-1430.

DOI: 10.1248/cpb.58.1423

Google Scholar

[12] M.P. Patel, R. Ravi, J.K. Patel, Chitosan mediated targeted drug delivery system: A review, J. Pharm. Pharmaceut. Sci. 13 (2010) 536-557.

DOI: 10.18433/j3jc7c

Google Scholar

[13] J.R. Joshi, R.P. Patel, Role of biodegradable polymers in drug delivery, Int. J. Curr. Pharm. Res. 4(4) (2012) 74-81.

Google Scholar

[14] F. Wu, Z. Zhou, J. Su, L. Wei, W. Yuan, T. Jin, Development of dextran nanoparticles for stabilizing delicate proteins, Nanoscale Res. Lett. (2013) 1-8.

DOI: 10.1186/1556-276x-8-197

Google Scholar

[15] H. Wang, M. Roman, Formation and properties of chitosan—cellulose nanocrystal polyelectrolyte−macroion complexes for drug delivery applications, Biomacromolecules 12 (2011) 1585-1593.

DOI: 10.1021/bm101584c

Google Scholar

[16] A.O. Elzoghby, Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research, J. Control. Release 172 (2013) 1075-1091.

DOI: 10.1016/j.jconrel.2013.09.019

Google Scholar

[17] R.C. Oppenhiem, Paclitaxel loaded gelatin nanoparticles for intravesical bladder cancer therapy, Int. J. Pharm. 8 (1981) 217.

Google Scholar

[18] M.F. Zambaux, F. Bonneaux, R. Gref, E. llacherie, C. Gneron, Preparation and characterization of protein C-loaded PLA nanoparticles, J. Control. Release 60 (1999) 179-188.

DOI: 10.1016/s0168-3659(99)00073-5

Google Scholar

[19] Z. Lu, T.K. Yeh, M. Tsai, J.L. Au, M.G. Wientjes, Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy, Clin. Cancer Res. 10 (2004) 7677-7679.

DOI: 10.1158/1078-0432.ccr-04-1443

Google Scholar

[20] G. Kaul, M. Amiji, Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery, Pharm. Res. 19 (2002) 1062-1068.

Google Scholar

[21] G. Kaul, M. Amiji, Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles, J. Pharm. Sci. 94 (2005) 184-198.

DOI: 10.1002/jps.20216

Google Scholar

[22] A. Kumari, S.K. Yadav, S.C. Yadav, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf., B. 75 (2010) 1-18.

DOI: 10.1016/j.colsurfb.2009.09.001

Google Scholar

[23] K.S. Soppimath, T.M. Aminabhav, A.R. Kulkarni, W.E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release 70 (2001) 1-20.

DOI: 10.1016/s0168-3659(00)00339-4

Google Scholar

[24] L. Nobs, F. Buchegger, R. Gurny, E. Allémann, Poly(lactic acid) nanoparticles labeled with biologically active neutravidin for active targeting, Eur. J. Pharm. Biopharm. 58 (2004) 483-490.

DOI: 10.1016/j.ejpb.2004.04.006

Google Scholar

[25] V.P. Torchillin, Multifunctional nanocarriers, Adv. Drug Deliv. Rev. 58 (2006) 1532-1555.

Google Scholar

[26] K. Derakhshandeh, M. Erfan, S. Dadashzadeh, Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics, Eur. J. Pharm. Biopharm. 66 (2007) 34-41.

DOI: 10.1016/j.ejpb.2006.09.004

Google Scholar

[27] W. Hasan, K. Chu, A. Gullapalli, S.S. Dunn, E.M. Enlow, J.C. Luft, S. Tian, M.E. Napier, P.D. Pohlhaus, J.P. Rolland, J.M. DeSimone, Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer, Nano. Lett. 12 (2011).

DOI: 10.1021/nl2035354

Google Scholar

[28] C.P. Reis, R.J. Neufeld, A.J. Ribeiro, F. Veiga, Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles, NBM 2 (2006) 8-21.

DOI: 10.1016/j.nano.2005.12.003

Google Scholar

[29] J. Matsumoto, Y. Nakada, K. Sakurai, T. Nakamura, Y. Takahashi, Preparation of nanoparticles consisted of poly(lactide)–poly(ethylene glycol)–poly(l-lactide) and their evaluation in vitro, Int. J. Pharm. 185 (1999) 93-101.

DOI: 10.1016/s0378-5173(99)00153-2

Google Scholar

[30] W. Zou, C. Liu, Z. Chen, N. Zhang, Preparation and characterization of cationic PLA-PEG nanoparticles for delivery of plasmid DNA, Nanoscale Res. Lett. 4 (2009) 982-989.

DOI: 10.1007/s11671-009-9345-3

Google Scholar

[31] C. Choi, S.Y. Chae, J.W. Nah, Thermosensitive poly(N-isopropylacrylamide)-b-poly([epsilon]-caprolactone) nanoparticles for efficient drug delivery system, Polymer 47 (2006) 4571-4580.

DOI: 10.1016/j.polymer.2006.05.011

Google Scholar

[32] M.S. Espuelas, P. Legrand, P.M. Loiseau, C. Bories, G. Barratt, J.M. Irache, In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres, J. Drug Target. 10 (2002) 593-599.

DOI: 10.1080/1061186021000060738

Google Scholar

[33] Y. Rosiaux, V. Jannin, S. Hughes, D. Marchaud, Solid lipid excipients — Matrix agents for sustained drug delivery, J. Control. Release 188 (2014) 18-30.

DOI: 10.1016/j.jconrel.2014.06.004

Google Scholar

[34] K. Mitri, R. Shegokar, S. Gohla, C. Anselmi, R.H. Müller, Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance, Int. J. Pharm. 414 (2011) 267-275.

DOI: 10.1016/j.ijpharm.2011.05.008

Google Scholar

[35] A.L. Weiner, Encyclopedia of pharmaceutical technology, New York, 2001, pp.1659-1673.

Google Scholar

[36] G.N. Fetih, Formulation and characterization of gelucire pellets for sustained release of Ibuprofen, Bull. Pharm. Sci. 33 (2010) 217-224.

DOI: 10.21608/bfsa.2010.64767

Google Scholar

[37] M.R. Rao, A.A. Ranpise, K.C. Thanki, S.G. Borate, G.N. Parikh, Effect of processing and sintering on controlled release wax matrix tablets of ketorolac tromethamine, Indian J. Pharm. Sci. 71 (2009) 538-544.

DOI: 10.4103/0250-474x.58188

Google Scholar

[38] H.G. Schroeder, A. Dakkuri, P.P. DeLuca, Sustained release from inert wax matrixes I: drug–wax combinations, J. Pharm. Sci. 67 (1978) 350-353.

DOI: 10.1002/jps.2600670320

Google Scholar

[39] P.C. Christophersen, L. Zhang, A. Müllertz, H.M. Nielsen, M. Yang, H. Mu, Solid lipid particles for oral delivery of peptide and protein drugs II – The digestion of trilaurin protects desmopressin from proteolytic degradation. doi10. 1007/s11095-014-1337-z, Pharm. Res. (2014).

DOI: 10.1007/s11095-014-1337-z

Google Scholar

[40] J. Sun, C. Bi, H.M. Chan, S. Sun, Q. Zhang, Y. Zheng, Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability, Colloids Surf., B. 111 (2013) 367-375.

DOI: 10.1016/j.colsurfb.2013.06.032

Google Scholar

[41] A. Leonardia, C. Bucolob, L.G. Romanob, C.B.M. Plataniab, F. Dragob, G. Puglisia, R. Pignatelloa, Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles, Int. J. Pharm. (2014).

Google Scholar

[42] S. Das, W. Kiong Ng, R.B.H. Tan, Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles, Nanotechnology 25 (2014).

DOI: 10.1088/0957-4484/25/10/105101

Google Scholar

[43] P. Chattopadhyay, B.Y. Shekunov, D. Yim, D. Cipolla, B. Boyd, S. Farr, Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system, Adv. Drug Deliv. Rev. 59 (2007).

DOI: 10.1016/j.addr.2007.04.010

Google Scholar

[44] M. Schoenitza, S. Josephb, A. Nitza, H. Bunjesb, S. Scholla, Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: A feasibility study, Eur. J. Pharm. Biopharm 86 (2014) 324-331.

DOI: 10.1016/j.ejpb.2013.08.009

Google Scholar

[45] E.B. Souto, S.A. Wissing, C.M. Barbosa, R.H. Muller, Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations, J. Cosmet. Sci 55 (2004) 463-471.

DOI: 10.1111/j.1467-2494.2004.00252_4.x

Google Scholar

[46] P.O. Nnamania, E.C. Ibezima, A.A. Attamaa, M.U. Adikwua, Surface modified solid lipid microparticles based on homolipids and Softisan® 142: preliminary characterization, Asian Pac. J. Trop. Med. 3 (2010) 205-210.

DOI: 10.1016/s1995-7645(10)60010-7

Google Scholar

[47] A. Nagi, R. Abdullah, S. Ibrahim, A. Bustamam, Tamoxifen drug loading solid lipid nanoparticles prepared by hot high pressure homogenization techniques, Am. J. Pharmacol. Toxicol. 3 (2008) 219-224.

DOI: 10.3844/ajptsp.2008.219.224

Google Scholar

[48] G. Abdelbary, R.H. Fahmy, Diazepam-loaded solid lipid nanoparticles: Design and characterization, AAPS PharmSci. Tech. 10 (2009) 211-219.

DOI: 10.1208/s12249-009-9197-2

Google Scholar

[49] Y.C. Kuo, C.Y. Chung, Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir, Colloids Surf., B. 88 (2011) 682-690.

DOI: 10.1016/j.colsurfb.2011.07.060

Google Scholar

[50] V. Kakkar, A.K. Mishra, K. Chuttani, K. Chopra, I.P. Kaur, Delivery of sesamol loaded solid lipid nanoparticles to brain for menopause related emotional and cognitive central nervous system derangements, Rejuvenation Res. 14 (2011) 597-604.

DOI: 10.1089/rej.2011.1193

Google Scholar

[51] E. Zimmermann, E.B. Souto, R.H. Müller, Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR., Pharmazie. 60 (2005) 508-513.

Google Scholar

[52] J. Pardeike, S. Weber, T. Haber, J. Wagner, H.P. Zarfl, H. Plank, Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application, Int. J. Pharm. 419 (2011) 329-338.

DOI: 10.1016/j.ijpharm.2011.07.040

Google Scholar

[53] A.R. Radomska-Soukharev, Stability of lipid excipients in solid lipid nanoparticles, Adv. Drug Deliv. Rev. 59 (2007) 411-418.

DOI: 10.1002/chin.200748265

Google Scholar

[54] C.H. Liu, C.T. Wu, Optimization of nanostructured lipid carriers for lutein delivery, Colloids and Surfaces A: Physicochem. Eng. Aspects 353 (2010) 149-156.

DOI: 10.1016/j.colsurfa.2009.11.006

Google Scholar

[55] M. Fathi, J. Varshosaz, M. Mohebbi, F. Shahidi, Hesperetin-loaded solid lipid nanoparticles and nanostructure lipid carriers for food fortification: Preparation, characterization, and modeling, Food Process Biotechnol. 6 (2013) 1464-1475.

DOI: 10.1007/s11947-012-0845-2

Google Scholar

[56] C. Guo, C. Yanga, Q. Li, Q. Tan, Y. Xi, W. Liud, Z. Guang, Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery, Int. J. Pharm. 430 (2012) 292-298.

DOI: 10.1016/j.ijpharm.2012.03.042

Google Scholar

[57] F.Q. Hu, S.P. Jiang, Y.Z. Du, H. Yuan, Y.Q. Ye, S. Zeng, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system, Colloids Surf., B. 45 (2005) 167-173.

DOI: 10.1016/j.colsurfb.2005.08.005

Google Scholar

[58] S. Xie, L. Zhu, Z. Dong, X. Wang, Y. Wang, X. Li, W. Zhou, Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids., Colloids Surf., B. 83 (2011) 382-387.

DOI: 10.1016/j.colsurfb.2010.12.014

Google Scholar

[59] J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chen, Q. Zhang, Q. He, Z. Zhang, Solid lipid nanoparticles for pulmonary delivery of insulin, Int. J. Pharm. 356 (2008) 333-344.

DOI: 10.1016/j.ijpharm.2008.01.008

Google Scholar

[60] P.R. Zhang, Y.F. Tu, S. Wang, Y.H. Wang, Y. Xie, M. Li, Y.G. Jin, Preparation and characterization of budesonide-loaded solid lipid nanoparticles for pulmonary delivery, J. Chin. Pharm. Sci. 20 (2011) 390-396.

DOI: 10.5246/jcps.2011.04.049

Google Scholar

[61] R.M. Khalil, A. Abd-Elbary, M.A. Kassem, M.M. Ghorab, M. Basha, Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam, Pharm. Dev. Technol. 19 (2014) 304-314.

DOI: 10.3109/10837450.2013.778872

Google Scholar

[62] J. Shen, M. Sun, Q. Ping, Z. Ying, W. Liu, Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement, Nanotechnology 15 (2010) 1-23.

DOI: 10.1088/0957-4484/21/2/025101

Google Scholar

[63] E.B. Souto, R.H. Müller, SLN and NLC for topical delivery of ketoconazole, J. Microencapsulation 22 (2005) 501-510.

DOI: 10.1080/02652040500162436

Google Scholar

[64] M.J. Tsai, P.C. Wu, Y.B. Huang, J.S. Chang, C.L. Lin, T.H. Tsai, J.Y. Fang, Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting, Int. J. Pharm. 423 (2012) 461-470.

DOI: 10.1016/j.ijpharm.2011.12.009

Google Scholar

[65] A. Chinsriwongkul, P. Chareanputtakhun, T. Ngawhirunpat, T. Rojanarata, W. Sila-on, U. Ruktanonchai, P. Opanasopit, Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug, AAPS Pharm. Sci. Tech. 13 (2011) 150-158.

DOI: 10.1208/s12249-011-9733-8

Google Scholar

[66] Y.C. Kuo, J.F. Chung, Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers, Colloids Surf., B. 83 (2011) 299-300.

DOI: 10.1016/j.colsurfb.2010.11.037

Google Scholar

[67] J. Varshosaz, S. Eskandari, M. Tabakhian, Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design, Pharm. Dev. Technol. 15 (2010) 89-96.

DOI: 10.3109/10837450903013568

Google Scholar

[68] J. Varshosaz, S. Eskandari, M. Tabbakhian, Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants, Carbohydr. Polym. 88 (2012) 1157-1163.

DOI: 10.1016/j.carbpol.2012.01.051

Google Scholar

[69] S. Kheradmandnia, E. Vasheghani-Farahani, M. Nosrati, F. Atyabi, Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax, Nanomedicine: Nanotechnology, Biology and Medicine 6 (2010).

DOI: 10.1016/j.nano.2010.06.003

Google Scholar

[70] G.D. Quintanar, Z.M. Zambrano, C.A. Alvarez, S.E. Mercado, Composition of solid lipid nanoparticles for the long-term conservation of fruits, vegetables, seeds, cereals and/or fresh foodstuffs using a coating EP2698066 A2, (2014).

Google Scholar

[71] H.M. Nguyen, I.C. Hwang, J.W. Park, H.J. Park, Photoprotection for deltamethrin using chitosan-coated beeswax solid lipid nanoparticles, Pest. Manag. Sci. 68 (2012a) 1062-1068.

DOI: 10.1002/ps.3268

Google Scholar

[72] A.A. Attama, C.C. Muller-Goymann, Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity, Colloids and Surfaces A: Physicochem. Eng. Aspects 315 (2008) 189-195.

DOI: 10.1016/j.colsurfa.2007.07.035

Google Scholar

[73] S. Eskandari, J. Varshosaz, M. Minaiyan, M. Tabbakhian, Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model, Int. J. Nanomedicine 6 (2011).

DOI: 10.2147/ijn.s15881

Google Scholar

[74] H. Ali, K. El-Sayed, P.W. Sylvester, S. Nazzal, Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: Evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy (1H NMR), Colloids Surf., B. 77 (2010).

DOI: 10.1016/j.colsurfb.2010.02.003

Google Scholar

[75] W.M. Obeidat, K. Schwabe, R.H. Müller, C.M. Keck, Preservation of nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 76 (2010) 56-67.

DOI: 10.1016/j.ejpb.2010.05.001

Google Scholar

[76] T. Delmas, A. Fraichard, P.A. Bayle, I. Texier, M. Bardet, J. Baudry, J. Bibette, A.C. Couffin, Encapsulation and release behavior from lipid nanoparticles: Model study with nile red fluorophore, Journal of Colloid Science and Biotechnology 1 (2012).

DOI: 10.1166/jcsb.2012.1010

Google Scholar

[77] P. Charoenputtakhun, P. Opanasopit, T. Rojanarata, T. Ngawhirunpat, All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier, Pharm. Dev. Technol. 19 (2014) 164-172.

DOI: 10.3109/10837450.2013.763261

Google Scholar

[78] T. Zhang, J. Chen, Y. Zhang, Q. Shen, W. Pan, Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide, Eur. J. Pharm. Sci. 43 (2011) 174-179.

DOI: 10.1016/j.ejps.2011.04.005

Google Scholar

[79] R. Abbasalipourkabir, A. Salehzadeh, R. Abdullah, Characterization and stability of nanostructured lipid carriers as drug delivery system, Pak. J. Biol. Sci. 15 (2012) 141-146.

DOI: 10.3923/pjbs.2012.141.146

Google Scholar

[80] S. Xie, B. Pan, M. Wang, L. Zhu, F. Wang, Z. Dong, X. Wang, W. Zhou, Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles, Nanomedicine 5 (2010) 693-701.

DOI: 10.2217/nnm.10.42

Google Scholar

[81] S. Xie, F. Wang, Y. Wang, L. Zhu, Z. Dong, X. Wang, X. Li, W. Zhou, Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles, Part. Fibre Toxicol. 8 (2011) 1-11.

DOI: 10.1186/1743-8977-8-33

Google Scholar

[82] H.M. Nguyen, I.C. Hwang, J.W. Park, H.J. Park, Enhanced payload and photo-protection for pesticides using nanostructured lipid carriers with corn oil as liquid lipid, J. Microencapsulation 29 (2012b) 596-604.

DOI: 10.3109/02652048.2012.668960

Google Scholar

[83] G.L. Hasenhuettl, Overview of food emulsifiers, Food emulsifiers and their applications (2008) 1-10.

DOI: 10.1007/978-0-387-75284-6_1

Google Scholar

[84] D.J. McClements, Food emulsions: principles, practice, and techniques, CRC Press, London, (2005).

Google Scholar

[85] S. Doktorovová, J. Araújo, M.L. Garcia, E. Rakovsky, E.B. Souto, Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC), Colloids Surf., B 75 (2010) 538-542.

DOI: 10.1016/j.colsurfb.2009.09.033

Google Scholar

[86] J.Y. Fang, C.L. Fang, C.H. Liu, Y.H. Su, Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 70 (2008) 633–640.

DOI: 10.1016/j.ejpb.2008.05.008

Google Scholar

[87] M. Fathi, M.R. Mozafari, M. Mohebbi, Nanoencapsulation of food ingredients using lipid based delivery systems, Trends Food Sci. Tech. 23 (2012) 13–27.

DOI: 10.1016/j.tifs.2011.08.003

Google Scholar

[88] F. Han, S. Li, R. Yin, H. Liu, L. Xu, Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers, Colloids and Surfaces A: Physicochem. Eng. Aspects 315(1–3) (2008).

DOI: 10.1016/j.colsurfa.2007.08.005

Google Scholar

[89] X. Huang, Y.J. Chen, D.Y. Peng, Q.L. Li, X.S. Wang, D.L. Wang, Solid lipid nanoparticles as delivery systems for Gambogenic acid, Colloids Surf. B 102 (2013) 391–397.

DOI: 10.1016/j.colsurfb.2012.08.058

Google Scholar

[90] I. Lacatusu, N. Badea, O. Ovidiu, D. Bojin, A. Meghea, Highly antioxidant carotene-lipid nanocarriers: Synthesis and antibacterial activity, J. Nanopart. Res. 14 (2012) 1-16.

DOI: 10.1007/s11051-012-0902-9

Google Scholar

[91] F. Li, Y. Weng, L. Wang, H. He, J. Yang, X. Tang, The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers, Int. J. Pharm. 393 (2010) 203–211.

DOI: 10.1016/j.ijpharm.2010.04.005

Google Scholar

[92] K. Zheng, A. Zou, X. Yang, F. Liu, Q. Xia, R. Ye, The effect of polymer surfactant emulsifying agent on the formation and stability of a-lipoic acid loaded nanostructured lipid carriers (NLC), Food Hydrocolloids 32(1) (2013) 72–78.

DOI: 10.1016/j.foodhyd.2012.11.006

Google Scholar

[93] I.P. Kaur, R. Bhandari, S. Bhandari, V. Kakkar, Potential of solid lipid nanoparticles in brain targeting, J. Control. Release 127 (2008) 97-109.

DOI: 10.1016/j.jconrel.2007.12.018

Google Scholar

[94] C.C. Trujillo, A.J. Wright, Properties and stability of solid lipid particle dispersions based on canola stearin and Poloxamer 188, J. Am. Oil Chem. Soc. 87 (2010) 715–730.

DOI: 10.1007/s11746-010-1553-6

Google Scholar

[95] T. Henning, Polyethylene glycols (PEGs) and the pharmaceutical industry, Fine, Speciality & Performance Chemicals (2002) 57-59.

Google Scholar

[96] O. Chambin, V. Jannin, Interest of multifunctional lipid excipients: Case of Gelucire® 44/14, Drug Dev. Ind. Pharm. 31(6) (2005) 527–534.

DOI: 10.1080/03639040500215750

Google Scholar

[97] S. Kumar, J. Kaur, Effect of surfactant on temperature stability of solid lipid nanoparticles studied by dynamic light scattering, AIP Conf. Proc. 163 (2013) 1536.

DOI: 10.1063/1.4810151

Google Scholar

[98] C.C. Chen, T.H. Tsai, Z.R. Huang, J.Y. Fang, Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics, Eur. J. Pharm. Biopharm. 74 (2010).

DOI: 10.1016/j.ejpb.2009.12.008

Google Scholar

[99] K. Cholkar, S. Hariharan, S. Gunda, A.K. Mitra, Optimization of dexamethasone mixed nanomicellar formulation doi: 10. 1208/s12249-014-0159-y, AAPS PharmSci. Tech. (2014).

DOI: 10.1208/s12249-014-0159-y

Google Scholar

[100] M.T. Sheu, S.Y. Chen, L.C. Chen, Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol, J. Control. Release 88 (2003) 355–368.

DOI: 10.1016/s0168-3659(02)00492-3

Google Scholar

[101] T. Madheswaran, R. Baskaran, C.S. Yong, B.K. Yoo, Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants doi: 10. 1208/s12249-013-0034-2, AAPS Pharm Sci. Tech. 15(1) (2014).

DOI: 10.1208/s12249-013-0034-2

Google Scholar

[102] Y. Chen, D. Liu, J. Liu, T. Chang, H. Ho, M. Sheu, Development of terbinafine solid lipid nanoparticles as a topical delivery system, Int. J. Nanomedicine 7 (2012) 4409–4418.

DOI: 10.2147/ijn.s33682

Google Scholar

[103] F. Mickler, L. Mockl, N. Ruthardt, M. Ogris, E. Wagner, C. Bräuchle, Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand, Nano Lett. 12 (2012).

DOI: 10.1021/nl300395q

Google Scholar

[104] A. Babu, A.K. Templeton, A. Munshi, R. Ramesh, Nanoparticle-based drug delivery for therapy of lung cancer: Progress and challenges, J. Nanomater. 2013 (2013) 1-12.

DOI: 10.1155/2013/863951

Google Scholar

[105] L.B. Peppas, J.O. Blanchette, Nanoparticle and targeted systems for cancer therapy, Adv. Drug Deliv. Rev. 64 (2012) 206-212.

DOI: 10.1016/j.addr.2012.09.033

Google Scholar

[106] Y. Zheng, H. Chen, X. Zeng, Z. Liu, X. Xiao, Y. Zhu, D. Gu, L. Mei, Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy doi: 10. 1186/1556-276X-8-161, Nanoscale Res. Lett. 8 (2013).

DOI: 10.1186/1556-276x-8-161

Google Scholar

[107] Y. Meihua, J. Siddharth, T. Peter, C. Jiezhong, G. Wenyi, Y. Chengzhong, Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells doi: 10. 1039/c2nr32145a, Nanoscale 5 (2013).

DOI: 10.1039/c2nr32145a

Google Scholar

[108] I.P. Kaur, S. Kakkar, M. Yadav, K. Jindal, I. Sharma, Autoclavable nanovesicular composition 700/Del/2014, (2014).

Google Scholar

[109] I.P. Kaur, H. Singh, Preparation of solid lipid nanoparticles of rifampicin to improve bioavailability and limiting drug interaction with isoniazid, India Patent, 17/01/2013, (2013).

Google Scholar